AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks CLST Catalyst drops 081 in todays trading after posting Q3 2025 earnings with no published analyst estimates HST Host posts 66 percent EPS beat for Q4 2025 with shares rising modestly after earnings release What factors are influencing Calamos Conv CCD stock today CX Cemex delivers 725 percent Q1 2026 EPS upside shares notch a 107 percent gain in todays trading LSTR Landstar System posts narrow Q1 2026 earnings beat as shares rise 12 percent on positive investor reaction Should I hold or sell F5 FFIV stock today F5 Posts 195 Percent EPS Beat Tops Street Views HELE Helen of posts 154 percent Q1 2026 EPS beat over estimates shares rise 051 percent today